Prior studies by our laboratory have shown that vitamin D-deprivation for 11 to 18 weeks resulted in alterations in the lipid fluidity and fatty acid composition of phosphatidylcholine (PC) and phosphatidylethanolamine (PR) of rat proximal small intestinal brush- border membranes. Moreover, administration of 1,25(OH)2D3 to D-deprived animals rapidly (1-2 h) corrected these membrane alterations, temporally preceding the earliest detectable stimulation of transmucosal Ca2+ transport by this hormone )(5 h). These observations led us to hypothesize that these vitamin D-induced membrane changes were responsible for this hormone's effects and Ca2+ transport. Based on these prior findings, the overall goal of the present proposal is to determine whether these vitamin D-induced brush-border membrane alterations are indeed responsible for its Ca2+ transport effects. To achieve this goal, tow sets of experiments are planned. First, weanling male-Wistar rats will be deprived of dietary and light sources of vitamin D for 14 weeks (group A). Age-matched dietary D-replete rats will serve as controls (group B). Rats from each group will be treated with analogs of vitamin D or vehicle, respectively. After 2-5 h, the rats will be sacrificed and brush-border membrane vesicles isolated. These preparations will be examined and compared with respect to their: 1) lipid fluidity; 2) lipid composition including individual molecular species of PC nd PE; 3) Ca2+ transport; and 4) various enzymatic activities. Once these studies are accomplished, membranes will be prepared from animals i groups A and B and treated in vitro with nonspecific lipid transfer protein together with synthetic liposomes in order to enrich these membranes with specific molecular species of PC and/or PE found to be altered in the earlier studies (see above). After treatment, membrane vesicles from both groups will be analyzed and compared with respect to their lipid composition, Ca2+ transport and fluidity. It is anticipated that these experiments will increase our knowledge of the mechanism(s) involved i the action of vitamin D on intestinal calcium transport.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK039573-01A2
Application #
3239364
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1989-07-01
Project End
1992-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Khare, Sharad; Cerda, Sonia; Wali, Ramesh K et al. (2003) Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Res 63:3517-23
Wali, Ramesh K; Stoiber, Debra; Nguyen, Lan et al. (2002) Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiol Biomarkers Prev 11:1316-21
Wali, Ramesh K; Khare, Sharad; Tretiakova, Maria et al. (2002) Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol Biomarkers Prev 11:1653-62
Alrefai, W A; Scaglione-Sewell, B; Tyagi, S et al. (2001) Differential regulation of the expression of Na(+)/H(+) exchanger isoform NHE3 by PKC-alpha in Caco-2 cells. Am J Physiol Cell Physiol 281:C1551-8
Cerda, S R; Bissonnette, M; Scaglione-Sewell, B et al. (2001) PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 120:1700-12
Scaglione-Sewell, B A; Bissonnette, M; Skarosi, S et al. (2000) A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1. Endocrinology 141:3931-9
Chen, A; Davis, B H; Bissonnette, M et al. (1999) 1,25-Dihydroxyvitamin D(3) stimulates activator protein-1-dependent Caco-2 cell differentiation. J Biol Chem 274:35505-13
Wali, R K; Bissonnette, M; Skarosi, S et al. (1998) 1,25-Dihydroxyvitamin D3 targets PKC-betaII but not PKC-alpha to the basolateral plasma membranes of rat colonocytes. Biochem Biophys Res Commun 250:48-52
Scaglione-Sewell, B; Abraham, C; Bissonnette, M et al. (1998) Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res 58:1074-81
Abraham, C; Scaglione-Sewell, B; Skarosi, S F et al. (1998) Protein kinase C alpha modulates growth and differentiation in Caco-2 cells. Gastroenterology 114:503-9

Showing the most recent 10 out of 32 publications